Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
4(36%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
3
27%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting3
Active, not recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

active_not_recruiting19%
terminated19%
completed545%
recruiting327%
unknown19%

Recent Activity

4 active trials
Showing 5 of 11
recruiting

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)

NCT07435467
recruitingnot_applicable

A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer

NCT05639413
active_not_recruitingnot_applicable

Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections

NCT03819712
completed

Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)

NCT05886309
recruitingnot_applicable

Circulating Immunes Cells, Cytokines and Brain Radiotherapy

NCT05082961
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07435467

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)

Recruiting
NCT05639413Not Applicable

A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer

Recruiting
NCT03819712Not Applicable

Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections

Active Not Recruiting
NCT05886309

Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)

Completed
NCT05082961Not Applicable

Circulating Immunes Cells, Cytokines and Brain Radiotherapy

Recruiting
NCT05720728

Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients

Completed
NCT02618109Phase 4

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

Terminated
NCT03841409

Peak Plasma Levels of Bupivacaine After an Erector Spinae Block (ESP)

Completed
NCT03003845

S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain

Completed
NCT03920904

Peak Plasma Levels of Bupivacaine After a Pecto-Intercostal Fascial Block Post-Sternotomy for Cardiac Surgery

Completed
NCT04101604

Biomarkers of Common Eye Diseases

Unknown

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11